Skip to main content
SpringerLink
Log in

Buccal Delivery of Nanoparticles

  • Chapter
  • First Online:
Mucosal Delivery of Drugs and Biologics in Nanoparticles

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 41))

Abstract

The buccal route offers an alternative for drug administration due to its advantages, including the avoidance of the gastrointestinal tract, the hepatic first-pass, enzymatic degradation and chemical instability of certain molecules that would pose a challenge to formulate orally. Moreover, the oral cavity has a lower enzyme content than the rest of the gastrointestinal tract, predictable transit times, easy administration, and provides the opportunity to readily halt drug administration. Additionally, the oral cavity is an organized system with stratified epithelium that allows manufacturing of pharmaceutical forms for drug delivery.

Due to the possibilities offered by this route, recent research efforts have been conducted towards the use of nanotechnology to enable buccal drug delivery. In this chapter, we discuss the anatomy of the oral cavity, relevant characteristics of the epithelium to drug delivery and delivery system permeation, types of nanocarriers that have been reported to-date and toxicity studies addressing nanotechnology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fahr A, Liu X. Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv. 2007 Jul 1;4(4):403–16.

    Article  CAS  PubMed  Google Scholar 

  2. Fernandes GJ, Kumar L, Sharma K, Tunge R, Rathnanand M. A review on solubility enhancement of carvedilol—a BCS class II drug. J Pharm Innov. 2018 Sep 1;13(3):197–212.

    Article  Google Scholar 

  3. Sievens-Figueroa L, Bhakay A, Jerez-Rozo JI, Pandya N, Romañach RJ, Michniak-Kohn B, et al. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS class II drug nanoparticles for pharmaceutical applications. Int J Pharm. 2012 Feb 28;423(2):496–508.

    Article  CAS  PubMed  Google Scholar 

  4. Lam JKW, Xu Y, Worsley A, Wong ICK. Oral transmucosal drug delivery for pediatric use. Adv Drug Deliv Rev. 2014 Jun 30;73:50–62.

    Article  CAS  PubMed  Google Scholar 

  5. Morales JO, McConville JT. Manufacture and characterization of mucoadhesive buccal films. Eur J Pharm Biopharm. 2011 Feb 1;77(2):187–99.

    Article  CAS  PubMed  Google Scholar 

  6. Mahmoud GA, Ali AE-H, Raafat AI, Badawy NA, Elshahawy MF. Development of (acrylic acid/ polyethylene glycol)-zinc oxide mucoadhesive nanocomposites for buccal administration of propranolol HCl. Radiat Phys Chem. 2018 Jun 1;147:18–26.

    Article  CAS  Google Scholar 

  7. Mandel ID. The functions of saliva, the functions of saliva. J Dent Res. 1987 Feb 1;66(2_suppl):623–7.

    Article  PubMed  Google Scholar 

  8. Morales JO, Brayden DJ. Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles. Curr Opin Pharmacol. 2017 Oct 1;36:22–8.

    Article  CAS  PubMed  Google Scholar 

  9. Morales JO, Huang S, Williams RO, McConville JT. Films loaded with insulin-coated nanoparticles (ICNP) as potential platforms for peptide buccal delivery. Colloids Surf B Biointerfaces. 2014 Oct 1;122:38–45.

    Article  CAS  PubMed  Google Scholar 

  10. Montenegro-Nicolini M, Morales JO. Overview and future potential of buccal Mucoadhesive films as drug delivery Systems for Biologics. AAPS PharmSciTech. 2017 Jan 1;18(1):3–14.

    Article  CAS  PubMed  Google Scholar 

  11. Bir Pawan Kumar∗ and Sandeep Kumar. Fast dissolving films: an innovative approach to oral drug delivery. INDO Am J Pharm Sci 2018 May 12;05(05):3714–3719.

    CAS  Google Scholar 

  12. Teubl BJ, Stojkovic B, Docter D, Pritz E, Leitinger G, Poberaj I, et al. The effect of saliva on the fate of nanoparticles. Clin Oral Investig. 2018 Mar 1;22(2):929–40.

    Article  PubMed  Google Scholar 

  13. Konstantinova V, Ibrahim M, Lie SA, Birkeland ES, Neppelberg E, Marthinussen MC, et al. Nano-TiO2 penetration of oral mucosa: in vitro analysis using 3D organotypic human buccal mucosa models. J Oral Pathol Med. 2017 Mar;46(3):214–22.

    Article  CAS  PubMed  Google Scholar 

  14. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm. 2000 Jul 3;50(1):161–77.

    Article  PubMed  Google Scholar 

  15. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002 Nov 1;54:S131–55.

    Article  PubMed  Google Scholar 

  16. Schuh RS, Bruxel F, Teixeira HF. Physicochemical properties of lecithin-based nanoemulsions obtained by spontaneous emulsification or high-pressure homogenization. Quím Nova. 2014;37(7):1193–8.

    CAS  Google Scholar 

  17. Marques AC, Rocha AI, Leal P, Estanqueiro M, Lobo JMS. Development and characterization of mucoadhesive buccal gels containing lipid nanoparticles of ibuprofen. Int J Pharm. 2017 Nov 30;533(2):455–62.

    Article  CAS  PubMed  Google Scholar 

  18. Geszke-Moritz M, Moritz M. Solid lipid nanoparticles as attractive drug vehicles: composition, properties and therapeutic strategies. Mater Sci Eng C. 2016 Nov 1;68:982–94.

    Article  CAS  Google Scholar 

  19. Ezzati Nazhad Dolatabadi J, Omidi Y. Solid lipid-based nanocarriers as efficient targeted drug and gene delivery systems. TrAC Trends Anal Chem. 2016 Mar;77:100–8.

    Article  CAS  Google Scholar 

  20. Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): a potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol. 2013 Jul 1;19(Supplement C):29–43.

    Article  CAS  Google Scholar 

  21. Anselmo AC, Mitragotri S. A review of clinical translation of inorganic nanoparticles. AAPS J. 2015 May 9;17(5):1041–54.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Arriagada F, Correa O, Günther G, Nonell S, Mura F, Olea-Azar C, et al. Morin flavonoid adsorbed on mesoporous silica, a novel antioxidant nanomaterial. PLoS One. 2016 Nov 3;11(11):e0164507.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Tonga GY, Moyano DF, Kim CS, Rotello VM. Inorganic nanoparticles for therapeutic delivery: trials, tribulations and promise. Curr Opin Colloid Interface Sci. 2014 Apr 1;19(2):49–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Choi JS, Han S-H, Hyun C, Yoo HS. Buccal adhesive nanofibers containing human growth hormone for oral mucositis. J Biomed Mater Res B Appl Biomater. 104(7):1396–406.

    Google Scholar 

  25. Raafat AI, Mahmoud GA, Ali AE-H, Badawy NA, Elshahawy MF. In vitro evaluation of mucoadhesive and self-disinfection efficiency of (acrylic acid/polyethylene glycol)-silver nanocomposites for buccal drug delivery, in vitro evaluation of mucoadhesive and self-disinfection efficiency of (acrylic acid/polyethylene glycol)-silver nanocomposites for buccal drug delivery. J Bioact Compat Polym. 2018 Jan 1;33(1):95–115.

    Article  CAS  Google Scholar 

  26. Freag MS, Saleh WM, Abdallah OY. Laminated chitosan-based composite sponges for transmucosal delivery of novel protamine-decorated tripterine phytosomes: ex-vivo mucopenetration and in-vivo pharmacokinetic assessments. Carbohydr Polym. 2018 May 15;188:108–20.

    Article  CAS  PubMed  Google Scholar 

  27. Suh JW, Lee J-S, Ko S, Lee HG. Preparation and characterization of mucoadhesive buccal nanoparticles using chitosan and dextran sulfate. J Agric Food Chem. 2016 Jul 6;64(26):5384–8.

    Article  CAS  PubMed  Google Scholar 

  28. Mørck Nielsen H, Rømer RM. TR146 cells grown on filters as a model of human buccal epithelium: v. enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leu-enkephalin. Int J Pharm. 2000 May 10;200(2):261–70.

    Article  PubMed  Google Scholar 

  29. Patel VF, Liu F, Brown MB. Advances in oral transmucosal drug delivery. J Control Release. 2011 Jul 30;153(2):106–16.

    Article  CAS  PubMed  Google Scholar 

  30. Montero-Padilla S, Velaga S, Morales JO. Buccal dosage forms: general considerations for pediatric patients. AAPS PharmSciTech. 2017 Feb 1;18(2):273–82.

    Article  CAS  PubMed  Google Scholar 

  31. Ten NA. Cate’s Oral histology – E-book: development, structure, and function: Elsevier Health Sciences; 2014. 407 p.

    Google Scholar 

  32. Squier CA. The permeability of keratinized and nonkeratinized oral epithelium to horseradish peroxidase. J Ultrastruct Res. 1973 Jan 1;43(1):160–77.

    Article  CAS  PubMed  Google Scholar 

  33. Kinikoglu B, Damour O, Hasirci V. Tissue engineering of oral mucosa: a shared concept with skin. J Artif Organs. 2015 Mar 1;18(1):8–19.

    Article  CAS  PubMed  Google Scholar 

  34. Collins LMC, Dawes C. The surface area of the adult human mouth and thickness of the salivary film covering the teeth and Oral mucosa. J Dent Res. 1987 Aug 1;66(8):1300–2.

    Article  CAS  PubMed  Google Scholar 

  35. de Vries ME, Boddé HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst. 1991;8(3):271–303.

    PubMed  Google Scholar 

  36. Goodman CH, Squier CA. Blood flow in the oral mucosa of normal and atherosclerotic rhesus monkeys. J Oral Pathol Med. 17(1):34–8.

    Google Scholar 

  37. Wertz PW, Swartzendruber DC, Squier CA. Regional variation in the structure and permeability of oral mucosa and skin. Adv Drug Deliv Rev. 1993 Oct 1;12(1):1–12.

    Article  Google Scholar 

  38. Squier CA, Wertz PW. Permeability and the pathophysiology of oral mucosa. Adv Drug Deliv Rev. 1993 Oct 1;12(1):13–24.

    Article  Google Scholar 

  39. Goswami T, Jasti BR, Li X. Sublingual drug delivery. Crit Rev Ther Drug Carr Syst. 2008;25(5)

    Google Scholar 

  40. Shklar G. The effects of aging upon oral mucosa. J Invest Dermatol. 1966 Aug;47(2):115–20.

    Article  CAS  PubMed  Google Scholar 

  41. Abu Eid R, Sawair F, Landini G, Saku T. Age and the architecture of oral mucosa. Age. 2012 Jun;34(3):651–8.

    Article  CAS  PubMed  Google Scholar 

  42. Hill MW. Influence of age on the morphology and transit time of murine stratified squamous epithelia. Arch Oral Biol. 1988 Jan 1;33(4):221–9.

    Article  CAS  PubMed  Google Scholar 

  43. Sohi H, Ahuja A, Ahmad FJ, Khar RK. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm. 2010 Mar;36(3):254–82.

    Article  CAS  PubMed  Google Scholar 

  44. Squier C, Wertz P. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone M, Swarbrick J, editors. Oral mucosal drug delivery. New York: Marcel Dekker, Inc.; 1996. p. 1–26.

    Google Scholar 

  45. Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 2008;70(1):43–8.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Shidhaye SS, Saindane NS, Sutar S, Kadam V. Mucoadhesive bilayered patches for administration of sumatriptan succinate. AAPS PharmSciTech. 2008 Aug 5;9(3):909–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Satishbabu BK, Srinivasan BP. Preparation and evaluation of buccoadhesive films of atenolol. Indian J Pharm Sci. 2008;70(2):175–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Nappinnai M, Chandanbala R, Balaijirajan R. Formulation and evaluation of nitrendipine buccal films. Indian J Pharm Sci. 2008;70(5):631–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Diaz del Consuelo I, Falson F, Guy RH, Jacques Y. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl. J Control Release Off J Control Release Soc. 2007 Sep 26;122(2):135–40.

    Article  CAS  Google Scholar 

  50. Batista P, Castro PM, Madureira AR, Sarmento B, Pintado M. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides. Peptides. 2018 Mar 1;101:112–23.

    Article  CAS  PubMed  Google Scholar 

  51. Mouftah S, Abdel-Mottaleb MMA, Lamprecht A. Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles. Int J Pharm. 2016 Dec 30;515(1):565–74.

    Article  CAS  PubMed  Google Scholar 

  52. Martín MJ, Calpena AC, Fernández F, Mallandrich M, Gálvez P, Clares B. Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery. Carbohydr Polym. 2015 Mar 6;117:140–9.

    Article  CAS  PubMed  Google Scholar 

  53. El-Nahas AE, Allam AN, El-Kamel AH. Mucoadhesive buccal tablets containing silymarin Eudragit-loaded nanoparticles: formulation, characterisation and ex vivo permeation. J Microencapsul. 2017 Jul 4;34(5):463–74.

    Article  CAS  PubMed  Google Scholar 

  54. Hazzah HA, Farid RM, Nasra MMA, Hazzah WA, El-Massik MA, Abdallah OY. Gelucire-based nanoparticles for curcumin targeting to oral mucosa: preparation, characterization, and antimicrobial activity assessment. J Pharm Sci. 2015 Nov 1;104(11):3913–24.

    Article  CAS  PubMed  Google Scholar 

  55. Wan S, Sun Y, Qi X, Tan F. Improved bioavailability of poorly water-soluble drug curcumin in cellulose acetate solid dispersion. AAPS PharmSciTech. 2012 Mar 1;13(1):159–66.

    Article  CAS  PubMed  Google Scholar 

  56. Mohammed MA, Syeda JTM, Wasan KM, Wasan EK. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics. 2017 Nov;20:9(4).

    Google Scholar 

  57. Siepmann J, Siepmann F. Modeling of diffusion controlled drug delivery. J Control Release. 2012 Jul 20;161(2):351–62.

    Article  CAS  PubMed  Google Scholar 

  58. Kontogiannidou E, Andreadis DA, Zografos AL, Nazar H, Klepetsanis P, van der Merwe SM, et al. Ex vivo buccal drug delivery of ropinirole hydrochloride in the presence of permeation enhancers: the effect of charge. Pharm Dev Technol. 2017 Nov 17;22(8):1017–21.

    Article  CAS  PubMed  Google Scholar 

  59. Haque T, Talukder MMU. Chemical enhancer: a simplistic way to modulate barrier function of the stratum Corneum. Adv Pharm Bull. 2018 Jun;8(2):169–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Jain S, Indulkar A, Harde H, Agrawal AK. Oral mucosal immunization using glucomannosylated bilosomes. J Biomed Nanotechnol. 2014 Jun;10(6):932–47.

    Article  CAS  PubMed  Google Scholar 

  61. Mauro M, Crosera M, Bianco C, Bellomo F, Bovenzi M, Adami G, et al. In vitro permeability of silver nanoparticles through porcine oromucosal membrane. Colloids Surf B Biointerfaces. 2015 Aug 1;132:10–6.

    Article  CAS  PubMed  Google Scholar 

  62. Teubl BJ, Leitinger G, Schneider M, Lehr C-M, Fröhlich E, Zimmer A, et al. The buccal mucosa as a route for TiO2 nanoparticle uptake. Nanotoxicology. 2015 Feb 17;9(2):253–61.

    Article  CAS  PubMed  Google Scholar 

  63. Roblegg E, Fröhlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology. 2012 Jun 1;6(4):399–413.

    Article  CAS  PubMed  Google Scholar 

  64. Teubl BJ, Meindl C, Eitzlmayr A, Zimmer A, Fröhlich E, Roblegg E. In-Vitro permeability of neutral polystyrene particles via buccal mucosa. Small. 9(3):457–66.

    Google Scholar 

  65. Mašek J, Lubasová D, Lukáč R, Turánek-Knotigová P, Kulich P, Plocková J, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles – important step towards effective mucosal vaccines. J Control Release. 2017 Mar 10;249:183–95.

    Article  CAS  PubMed  Google Scholar 

  66. Gavin A, Pham JT, Wang D, Brownlow B, Elbayoumi TA. Layered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeutics. Int J Nanomedicine. 2015 Feb 23;10:1569–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Forstner J, Taichman N, Kalnins V, Forstner G. Intestinal goblet cell mucus: isolation and identification by immunofluorescence of a goblet cell glycoprotein. J Cell Sci. 1973 Mar 1;12(2):585–601.

    CAS  PubMed  Google Scholar 

  68. Morales JO, McConville JT. Novel strategies for the buccal delivery of macromolecules. Drug Dev Ind Pharm. 2014 May 1;40(5):579–90.

    Article  CAS  PubMed  Google Scholar 

  69. Horowitz M, Ward P. The Glycoconjugates. In: Mammalian glycoproteins and glycolipids: Elsevier; 2012. 579 p.

    Google Scholar 

  70. Bernkop-Schnürch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev. 2005 Nov 3;57(11):1569–82.

    Article  CAS  PubMed  Google Scholar 

  71. George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan — a review. J Control Release. 2006 Aug 10;114(1):1–14.

    Article  CAS  PubMed  Google Scholar 

  72. Vllasaliu D, Exposito-Harris R, Heras A, Casettari L, Garnett M, Illum L, et al. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. Int J Pharm. 2010 Nov 15;400(1):183–93.

    Article  CAS  PubMed  Google Scholar 

  73. Boddupalli BM, Mohammed ZNK, Nath RA, Banji D. Mucoadhesive drug delivery system: an overview. J Adv Pharm Technol Res. 2010;1(4):381–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005 Nov 3;57(11):1666–91.

    Article  CAS  PubMed  Google Scholar 

  75. Tejada G, Piccirilli GN, Sortino M, Salomón CJ, Lamas MC, Leonardi D. Formulation and in-vitro efficacy of antifungal mucoadhesive polymeric matrices for the delivery of miconazole nitrate. Mater Sci Eng C. 2017 Oct 1;79:140–50.

    Article  CAS  Google Scholar 

  76. Reda RI, Wen MM, El-Kamel AH. Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis. Int J Nanomedicine. 2017 Mar 27;12:2335–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Wen H. Park K, Oral controlled release formulation design and drug delivery: theory to practice: Wiley; 2011. 376 p.

    Google Scholar 

  78. Elkomy MH, Menshawe SFE, Abou-Taleb HA, Elkarmalawy MH. Loratadine bioavailability via buccal transferosomal gel: formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers. Drug Deliv. 2017 Jan 1;24(1):781–91.

    Article  CAS  PubMed  Google Scholar 

  79. Abruzzo A, Cerchiara T, Bigucci F, Gallucci MC, Luppi B. Mucoadhesive buccal tablets based on chitosan/gelatin microparticles for delivery of propranolol hydrochloride. J Pharm Sci. 2015 Dec 1;104(12):4365–72.

    Article  CAS  PubMed  Google Scholar 

  80. Donnelly RF, McCarron PA, Tunney MM, David WA. Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue O. J Photochem Photobiol B. 2007 Jan 3;86(1):59–69.

    Article  CAS  PubMed  Google Scholar 

  81. Singh S, Jain S, Muthu MS, Tiwari S, Tilak R. Preparation and evaluation of buccal bioadhesive films containing clotrimazole. AAPS PharmSciTech. 2008 Jun 1;9(2):660–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Montenegro-Nicolini M, Miranda V, Morales JO. Inkjet printing of proteins: an experimental approach. AAPS J. 2017 Jan 1;19(1):234–43.

    Article  CAS  PubMed  Google Scholar 

  83. Fritz H, Ortiz AC, Morales JO. Development of nifedipine-loaded nanoemulsions as Inks for Inkjet Printing of a BCS Class II Drug. In: AAPS Annual Meeting and Exposition. Denver, CO, USA; 2016, 2016.

    Google Scholar 

  84. Kraisit P, Limmatvapirat S, Luangtana-Anan M, Sriamornsak P. Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles. Asian J Pharm Sci. 2018 Jan 1;13(1):34–43.

    Article  PubMed  Google Scholar 

  85. Hu D, Wang H, Wang L. Physical properties and antibacterial activity of quaternized chitosan/carboxymethyl cellulose blend films. LWT – Food Sci Technol. 2016 Jan 1;65:398–405.

    Article  CAS  Google Scholar 

  86. Nair AB, Al-ghanna AA, Al-Dhubiab BE, Hasan AA. Mucoadhesive film embedded with acyclovir loaded biopolymeric nanoparticles: in vitro studies. J Young Pharm. 2017;9(1):100–5.

    Article  CAS  Google Scholar 

  87. Barzoki ZM, Emam-Djomeh Z, Mortazavian E, Moosavi-Movahedi AA, Tehrani MR. Formulation, in vitro evaluation and kinetic analysis of chitosan–gelatin bilayer muco-adhesive buccal patches of insulin nanoparticles. J Microencapsul. 2016 Oct 2;33(7):613–24.

    Article  CAS  Google Scholar 

  88. Kianfar F, Chowdhry BZ, Antonijevic MD, Boateng JS. Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs. Drug Dev Ind Pharm. 2012 Oct 1;38(10):1207–20.

    Article  CAS  PubMed  Google Scholar 

  89. Giovino C, Ayensu I, Tetteh J, Boateng JS. An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf B Biointerfaces. 2013 Dec 1;112:9–15.

    Article  CAS  PubMed  Google Scholar 

  90. Velten T, Schuck H, Knoll T, Scholz O, Schumacher A, Göttsche T, et al. Intelligent intraoral drug delivery microsystem. Proc Inst Mech Eng Part C J Mech Eng Sci. 2006 Nov 1;220(11):1609–17.

    Article  Google Scholar 

  91. Li H, Yu Y, Dana SF, Li B, Lee C-Y, Kang L. Novel engineered systems for oral, mucosal and transdermal drug delivery. J Drug Target. 2013 Aug 1;21(7):611–29.

    Article  CAS  PubMed  Google Scholar 

  92. Andreani T, Kiill CP, de Souza ALR, Fangueiro JF, Fernandes L, Doktorovová S, et al. Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies. Colloids Surf B Biointerfaces. 2014 Nov 1;123:916–23.

    Article  CAS  PubMed  Google Scholar 

  93. Iglesias T, López de Cerain A, Irache J, Martín-Arbella N, Wilcox M, Pearson J, et al. Evaluation of the cytotoxicity, genotoxicity and mucus permeation capacity of several surface modified poly(anhydride) nanoparticles designed for oral drug delivery. Int J Pharm. 2017 Jan 30;517(1):67–79.

    Article  CAS  PubMed  Google Scholar 

  94. Klemetsrud T, Kjøniksen A-L, Hiorth M, Jacobsen J, Smistad G. Polymer coated liposomes for use in the oral cavity – a study of the in vitro toxicity, effect on cell permeability and interaction with mucin. J Liposome Res. 2018 Jan 2;28(1):62–73.

    Article  CAS  PubMed  Google Scholar 

  95. Wei X, Shao B, He Z, Ye T, Luo M, Sang Y, et al. Cationic nanocarriers induce cell necrosis through impairment of Na+/K+-ATPase and cause subsequent inflammatory response. Cell Res. 2015 Feb;25(2):237–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Juliano C, Galleri G, Klemetsrud T, Karlsen J, Giunchedi P. Effect of chitosan malate on viability and cytoskeletal structures morphology of Caco-2 cells. Int J Pharm. 2011 Nov 28;420(2):223–30.

    Article  CAS  PubMed  Google Scholar 

  97. Huang M, Khor E, Lim L-Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res. 2004 Feb;21(2):344–53.

    Article  CAS  PubMed  Google Scholar 

  98. Kean T, Thanou M. Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. 2010 Jan 31;62(1):3–11.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors acknowledge the financial support of FONDECYT 1181689, FONDAP 15130011, and CONICYT 21180654.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Science and Technology, School of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile

    Andrea C. Ortiz & Javier O. Morales

  2. Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile

    Andrea C. Ortiz & Javier O. Morales

  3. Pharmaceutical and Biomaterial Research Group, Department of Health Sciences, Luleå University of Technology, Luleå, Sweden

    Javier O. Morales

Authors
  1. Andrea C. Ortiz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Javier O. Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Javier O. Morales .

Editor information

Editors and Affiliations

  1. Department of Pharmaceutical Sciences, College Pharmacy, University of New Mexico, Albuquerque, NM, USA

    Pavan Muttil

  2. Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences, St. John’s University, Jamaica, NY, USA

    Nitesh K. Kunda

Rights and permissions

Reprints and permissions

Copyright information

© 2020 American Association of Pharmaceutical Scientists

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ortiz, A.C., Morales, J.O. (2020). Buccal Delivery of Nanoparticles. In: Muttil, P., Kunda, N. (eds) Mucosal Delivery of Drugs and Biologics in Nanoparticles. AAPS Advances in the Pharmaceutical Sciences Series, vol 41. Springer, Cham. https://doi.org/10.1007/978-3-030-35910-2_5

Download citation

Publish with us

Policies and ethics

Search

Navigation